Product Information
CHLORPROMAZINE 200 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.6636 per EA under NDC 68462086501. Its NADAC has been published 286 times since Apr 14, 2021.
FDA first approved this application on Mar 23, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462086501
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CHLORPROMAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212144FDA Approved
3/23/2021
TE Code
AB
On Market Since
3/23/2021
Pharmacological Classes
Price Statistics
The NADAC for CHLORPROMAZINE 200 MG TABLET has been published 286 times since Apr 14, 2021, and over the history we have for it it has declined 88.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6636 per EA |
|---|---|
| All-time high | $6.3685 (Nov 10, 2021) |
| All-time low | $0.6419 (Apr 22, 2026) |
| 52-week high | $1.2885 |
| 52-week low | $0.6419 |
| Median price | $1.3944 |
| Average price | $2.2203 |
| Largest weekly change | +59.5% (Nov 22, 2023) |
| Weeks tracked | 286 |
| Tracking since | Apr 14, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Chlorpromazine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHLORPROMAZINE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CHLORPROMAZINE 200 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.6636 per EA (NDC 68462086501), effective Sep 30, 2026.
How has the price of CHLORPROMAZINE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for CHLORPROMAZINE 200 MG TABLET has declined 88.7%. It has been tracked across 286 weekly CMS publications since Apr 14, 2021.
What are the highest and lowest recorded NADAC prices for CHLORPROMAZINE 200 MG TABLET?
Since Apr 14, 2021, the NADAC for CHLORPROMAZINE 200 MG TABLET has ranged from a low of $0.6419 (Apr 22, 2026) to a high of $6.3685 (Nov 10, 2021), with a median of $1.3944 per EA.
Are there cheaper alternatives to CHLORPROMAZINE 200 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CHLORPROMAZINE 200 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CHLORPROMAZINE 200 MG TABLET?
CHLORPROMAZINE 200 MG TABLET (NDC 68462086501) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.